↓ Skip to main content

Metabolic Activation of CPT-11, 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin, a Novel Antitumor Agent, by Carboxylesterase

Overview of attention for article published in Biological and Pharmaceutical Bulletin, January 1994
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Metabolic Activation of CPT-11, 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin, a Novel Antitumor Agent, by Carboxylesterase
Published in
Biological and Pharmaceutical Bulletin, January 1994
DOI 10.1248/bpb.17.662
Pubmed ID
Authors

T Satoh, M Hosokawa, R Atsumi, W Suzuki, H Hakusui, E Nagai

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 21 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 27%
Student > Master 3 14%
Student > Doctoral Student 1 5%
Student > Bachelor 1 5%
Student > Ph. D. Student 1 5%
Other 3 14%
Unknown 7 32%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 23%
Biochemistry, Genetics and Molecular Biology 3 14%
Agricultural and Biological Sciences 3 14%
Medicine and Dentistry 2 9%
Chemistry 1 5%
Other 0 0%
Unknown 8 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2013.
All research outputs
#5,763,776
of 26,451,184 outputs
Outputs from Biological and Pharmaceutical Bulletin
#400
of 3,300 outputs
Outputs of similar age
#5,484
of 71,500 outputs
Outputs of similar age from Biological and Pharmaceutical Bulletin
#5
of 71 outputs
Altmetric has tracked 26,451,184 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,300 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 71,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.